SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (120)11/18/1997 2:06:00 PM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 399
 
The Sankyo deal is worth $30-$35 million to ARQL. This information wasn't included in the press release for some reason. But, was released later.

This might make ARQL profitable. Amazing, for an early stage biotech!

I agree Rick, January is going to be something.

John de C